PepGen (PEPG) Earnings Date & Reports

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PEPG is expected to report earnings to rise 11.88% to -29 cents per share on August 06

Q2'26

Est.

$-0.29

Q1'26

Beat

by $0.03

Q4'25

Beat

by $0.10

Q3'25

Beat

by $0.04

Q2'25

Beat

by $0.11

The last earnings report on May 12 showed earnings per share of -25 cents, beating the estimate of -29 cents. With 306.24K shares outstanding, the current market capitalization sits at 101.68M.

View a ticker or compare two or three

Compare

PEPG

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for PEPG